Radiation dose from multidetector row CT imaging for acute stroke

被引:120
作者
Mnyusiwalla, Anisa [1 ]
Aviv, Richard I. [1 ]
Symons, Sean P. [1 ,2 ]
机构
[1] Univ Toronto, Sunnybrook Hlth Sci Ctr, Div Neuroradiol, Dept Med Imaging, Toronto, ON, Canada
[2] Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada
关键词
Computed tomography; Acute stroke; Radiation dose; Computed tomography angiography; Computed tomography perfusion; ACUTE ISCHEMIC-STROKE; ATOMIC-BOMB SURVIVORS; DIFFUSION-WEIGHTED MR; COMPUTED-TOMOGRAPHY; CANCER-RISKS; PERFUSION; PROUROKINASE; ANGIOGRAPHY; PROTOCOLS; PROACT;
D O I
10.1007/s00234-009-0543-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The objective of this study was to determine the radiation dose delivered during comprehensive computed tomography (CT) imaging for acute stroke. All CT examinations performed over 18 months using our acute stroke protocol were included. Protocol includes an unenhanced CT head, CT angiography from the arch to vertex, CT perfusion/permeability, and an enhanced CT head. All imaging was acquired with a 64-MDCT. Examinations where any element of the protocol was repeated or omitted due to mistimed injection or patient motion were excluded. Dose-length products (DLP) for all components of each examination were obtained from dose reports generated at the time of acquisition, separating neck, and head calculations. Effective doses for each examination were calculated using the DLP and normalized values of effective dose per DLP appropriate for the body regions imaged. Ninety-five examinations were included. Mean DLP was 6,790.0 mGy center dot cm. Effective doses ranged from 11.8 to 27.3 mSv, mean effective dose of 16.4 mSv. Mean effective dose for acquisition of the unenhanced head was 2.7 mSv. Largest contribution to effective dose was the CTA with a mean effective dose of 5.4 mSv. Mean effective dose for the CT perfusion was 4.9 mSv. A comprehensive CT acute stroke protocol delivered a mean effective dose of 16.4 mSv, which is approximately six times the dose of an unenhanced CT head. These high-dose results must be balanced with the benefits of the detailed anatomic and physiologic data obtained. Centers should implement aggressive dose reduction strategies and freely use MR as a substitute.
引用
收藏
页码:635 / 640
页数:6
相关论文
共 31 条
  • [1] [Anonymous], 2006, Radiobiology for the radiologist
  • [2] [Anonymous], 2006, Health risks from exposure to low levels of ionizing radiation BEIR VII, Phase 2
  • [3] Hemorrhagic Transformation of Ischemic Stroke: Prediction with CT Perfusion
    Aviv, Richard I.
    d'Esterre, Christopher D.
    Murphy, Blake D.
    Hopyan, Julia J.
    Buck, Brian
    Mallia, Gabriella
    Li, Vivian
    Zhang, Liying
    Symons, Sean P.
    Lee, Ting-Yim
    [J]. RADIOLOGY, 2009, 250 (03) : 867 - 877
  • [4] Clinical correlations of diffusion and perfusion lesion volumes in acute ischemic stroke
    Baird, AE
    Lövblad, KO
    Dashe, JF
    Connor, A
    Burzynski, C
    Schlaug, G
    Straroselskaya, I
    Edelman, RR
    Warach, S
    [J]. CEREBROVASCULAR DISEASES, 2000, 10 (06) : 441 - 448
  • [5] The 15-country collaborative study of cancer risk among radiation workers in the nuclear industry:: Estimates of radiation-related cancer risks
    Cardis, E.
    Vrijheid, M.
    Blettner, M.
    Gilbert, E.
    Hakama, M.
    Hill, C.
    Howe, G.
    Kaldor, J.
    Muirhead, C. R.
    Schubauer-Berigan, M.
    Yoshimura, T.
    Bermann, F.
    Cowper, G.
    Fix, J.
    Hacker, C.
    Heinmiller, B.
    Marshall, M.
    Thierry-Chef, I.
    Utterback, D.
    Ahn, Y-O
    Amoros, E.
    Ashmore, P.
    Auvinen, A.
    Bae, J-M.
    Bernar, J.
    Biau, A.
    Combalot, E.
    Deboodt, P.
    Sacristan, A. Diez
    Eklof, M.
    Engels, H.
    Engholm, G.
    Gulis, G.
    Habib, R. R.
    Holan, K.
    Hyvonen, H.
    Kerekes, A.
    Kurtinaitis, J.
    Malker, H.
    Martuzzi, M.
    Mastauskas, A.
    Monnet, A.
    Moser, M.
    Pearce, M. S.
    Richardson, D. B.
    Rodriguez-Artalejo, F.
    Rogel, A.
    Tardy, H.
    Telle-Lamberton, M.
    Turai, I.
    [J]. RADIATION RESEARCH, 2007, 167 (04) : 396 - 416
  • [6] Cohnen M, 2006, AM J NEURORADIOL, V27, P1741
  • [7] PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke
    del Zoppo, GJ
    Higashida, RT
    Furlan, AJ
    Pessin, MS
    Rowley, HA
    Gent, M
    [J]. STROKE, 1998, 29 (01) : 4 - 11
  • [8] Postcontrast CT Extravasation Is Associated With Hematoma Expansion in CTA Spot Negative Patients
    Ederies, Ashraf
    Demchuk, Andrew
    Chia, Tze
    Gladstone, David J.
    Dowlatshahi, Dar
    BenDavit, Gabriel
    Wong, Kelly
    Symons, Sean P.
    Aviv, Richard I.
    [J]. STROKE, 2009, 40 (05) : 1672 - 1676
  • [9] Intra-arterial prourokinase for acute ischemic stroke - The PROACT II study: A randomized controlled trial
    Furlan, A
    Higashida, R
    Wechsler, L
    Gent, M
    Rowley, H
    Kase, C
    Pessin, M
    Ahuja, A
    Callahan, F
    Clark, WM
    Silver, F
    Rivera, F
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21): : 2003 - 2011
  • [10] Hirata Masaaki, 2005, Radiat Med, V23, P162